| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |